Faculty Profile: William M. Sage
Main Profile Content
A.B., Harvard, 1982; M.D., J.D., Stanford, 1988. Docteur h.c., Universite Paris Descartes, 2011. Note editor, Stanford Law Review. Areas of teaching are health law, regulatory theory, antitrust, and professional responsibility. Visiting professor of law Emory 2018, Yale 2013, Harvard 2007, Duke 2001. Vice provost for health affairs, UT Austin 2006-13. Taught at Columbia Law School 1995-2006. Associate, O'Melveny & Myers, Los Angeles, 1990-95. President's Task Force on Health Care Reform, 1993. Resident in anesthesiology and critical care medicine, The Johns Hopkins Hospital, 1989-90. Intern, Mercy Hospital and Medical Center, San Diego, 1988-89.
Member, National Academy of Medicine; Member, Board on Health Care Services, National Academies of Science; Member, The Academy of Medicine, Engineering, and Science of Texas; Fellow, Hastings Center on bioethics. Board chair, Children's Optimal Health. Serves on the editorial board of Health Affairs. Serves on the Code Red Task Force on the uninsured in Texas. Principal investigator, The Pew Charitable Trusts Project on Medical Liability in Pennsylvania (2002-05). Received Robert Wood Johnson Foundation Investigator Award in Health Policy Research (1998).
Co-editor, Oxford Handbook of U.S. Health Law (Oxford University Press, 2017); Medical Malpractice and the U.S. Health Care System (Cambridge University Press, 2006), Uncertain Times: Kenneth Arrow and the Changing Economics of Health Care (Duke University Press, 2003). Articles include: "Regulating through Information: Disclosure Laws and American Health Care," Columbia Law Review (1999); "Antitrust, Health Care Quality, and the Courts," Columbia Law Review (with Hammer, 2002); "Medical Liability and Patient Safety," Health Affairs (2003); "Some Principles Require Principals: Why Banning 'Conflicts of Interest' Won’t Solve Incentive Problems in Biomedical Research," Texas Law Review (2007); "Relational Duties, Regulatory Duties, and the Widening Gap Between Individual Health Law and Collective Health Policy," Georgetown Law Journal (2008); "Combating Antimicrobial Resistance: Regulatory Strategies and Institutional Capacity," Tulane Law Review (with Hyman, 2010), "Brand New Law! The Need to Market Health Care Reform," University of Pennsylvania Law Review (2011), and "Assembled Products: The Key to More Effective Competition and Antitrust Oversight in Health Care" Cornell Law Review (2016).